U.K. sets timetable for containers
This article was originally published in The Tan Sheet
Executive Summary
Firms marketing nonprescription liquid cough and cold drugs in the U.K. must submit to health regulators by Feb. 12, 2010, plans for the child-resistant containers required by September 2010. The Medicines and Healthcare products Regulatory Agency Oct. 27 said it intends to approve changes by the end of March. MHRA imposed the regulation, which covers pharmacy-only and general-sale antihistamines, antitussives, expectorants and decongestants, following a comprehensive efficacy and safety review of children's cough/cold products. MHRA in February 2008 said children under 6 should not use OTC cough/cold products because of efficacy and safety concerns (1"The Tan Sheet" March 9, 2009)